Skip to main content
. 2023;24(3):897–907. doi: 10.31557/APJCP.2023.24.3.897

Table 1.

Comparison of the Results of the Current Investigation with the Available Literature for Real Time in-vivo Rectal Dose Measurements Made During HDR/MDR Brachytherapy Applications Using Various Types of Detectors

SN Author
(year of publication)
Source used Number of applications (n) Type of
Imaging
Type of
detector
DD (%)
Minimum to Maximum
(Mean ± SD)
1 *Eich et al.,
(2000)
Ir-192 11 2D based Diodes -50.0% to 40.0%
HDR ICBT (4.0% ± 19.0%)
2 *Waldhäusl et al.,
(2005)
Ir-192 50 2D based Diodes -31.0% to 90.0%
HDR ICBT (Mean 11.0%)
3 *Sha et al.,
(2011)
Ir-192 86 2D based Ionization <5% (n=52)
HDR ICBT chamber 5% - 10% (n=26)
10% - 14% (n = 8)
(Mean 3.8%)
4 *Allahverdi et al.,
(2013)
Cs-137 36 2D based Diodes -85.0% to 36.0%
MDR ICBT -3.00%
5 *Z.K.Zaman et al.,
(2014)
Co-60 11 CT based Diodes - 8.5% to 41.2%
HDR ICBT (Mean 2.6%)
6 **Carrara et al., (2016, 2017) Ir-192 77 CT based MOSkin -16.0% to 19.0%
HDR Prostate ( -- not quoted -- )
7 *Jamalludin et al.,
(2020)
Co-60 18 CT based MOSkin -16.3% to 14.9%
HDR ICBT (-3.2% ± 10.1%)
8 18 Diode -35.7% to -2.1%
(RP3) (-15.5% ± 9.7%)
9 48 Diode -37.1% to 11.0%
(RPmax) (Mean -13.5%)
10 * Johan et al., Co-60 € Phantom CT Diodes -15.6% to 11.8%
[Present study] (-2.0% ± 9.5%)
11 22 CT based -19.5% to 24.0%
HDR ICBT (0.7% ± 9.1%)

*, Gynecological brachytherapy applications.; **, Prostate brachytherapy applications.; n, number of applications; ICBT, Intracavitary cervix brachytherapy; 2D, Two dimensional (through orthogonal radiographs); HDR, High Dose Rate.; MDR, Medium Dose Rate.; CT, Computed Tomography.; RP3, Dose received to the third diode of rectum probe.; RPmax, Maximum dose received to the rectal point.; DD, Difference of measured and planned doses; SD, Standard Deviation; €, Measurements done in water phantom